1Y Target$58.06Near-term target
5Y Target$118.95Compound horizon
10Y Target$309.53Long-dated conviction
FCF$7.1bTTM · 03/26B+FCF $7.1b — strong cash profile, above most peers · TTM computed from 4 most-recent quarters (TTM · 03/26).
Rev+5.1%TTM YoYC+Revenue +5.1% — steady but below market-beating range
D/E0.76BD/E 0.76 — at market average, manageable
P/S0.2xAP/S 0.2x — deep value on sales
PEG1.13B+PEG 1.13 — near fair value, classic Lynch benchmark (1.0)
Why now
Healthcare Plans · market cap $29.2b. Trading near 52-week high of $60.76 — momentum setup, limited technical margin of safety. 17 sell-side analysts rate this a Buy with a mean 1-yr target of $58.06 (implying -2% upside).
Moat
Speculative bucket — the moat thesis is forward-looking; without proven margin structure or capital efficiency yet, the durability argument is about IP / network effects / first-mover position that the company hasn't fully monetized.
Risk
Currently unprofitable (margin -3.6%) — path to GAAP profitability is the core thesis risk. Trading within 3% of the 52-week high — limited technical margin of safety; a momentum reversal would test conviction. ROE -26% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
Horizon
1-3 yr $58.06 (17-analyst consensus) — catalyst-driven; binary events dominate. 5 yr $118.95 — requires the platform / technology to reach commercial scale. 10 yr $309.53 — return distribution heavily skewed.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See
terms and
methodology for full disclosures.